1. LncRNA HOTAIR promotes the proliferation and invasion/metastasis of breast cancer cells by targeting the miR-130a-3p/Suv39H1 axis
   Wenxing He et al, 2022, Biochemistry and Biophysics Reports CrossRef
2. Overcoming the acquired resistance to gefitinib in lung cancer brain metastasis in vitro and in vivo
   Zhongwei Liu et al, 2021, Archives of Toxicology CrossRef
3. WITHDRAWN: In vitro synergistic activity of cisplatin and EGFR-targeted nanomedicine of anti-Bcl-xL siRNA in a non-small lung cancer cell line model
   Phuoc Vinh Nguyen et al, 2023, International Journal of Pharmaceutics CrossRef
4. The drug efficacy testing in 3D cultures platform identifies effective drugs for ovarian cancer patients
   Emma Åkerlund et al, 2023, npj Precision Oncology CrossRef
5. Therapeutic potential of the novel Bcl‐2/Bcl‐XL dual inhibitor, APG1252, alone or in combination against non‐small cell lung cancer
   Luxi Qian et al, 2022, Molecular Carcinogenesis CrossRef
6. Osimertinib is a dual inhibitor of hepatocellular carcinoma and angiogenesis in an EGFR-independent manner, and synergizes with venetoclax
   Qiaoxin Huang et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
7. In vitro synergistic activity of cisplatin and EGFR-targeted nanomedicine of anti-Bcl-xL siRNA in a non-small lung cancer cell line model
   Phuoc Vinh Nguyen et al, 2022, International Journal of Pharmaceutics: X CrossRef
8. Specific Targeting of Antiapoptotic Bcl-2 Proteins as a Radiosensitizing Approach in Solid Tumors
   Benjamin Sobol et al, 2022, International Journal of Molecular Sciences CrossRef